WIN $150 GIFT VOUCHERS: ALADDIN'S GOLD

Close Notification

Your cart does not contain any items

Cardiac Drugs in Pregnancy

Karen Sliwa John Anthony

$115.95   $92.71

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Springer London Ltd
11 December 2013
​The spectrum of cardiovascular disease affecting women in pregnancy and postpartum is changing and differs between countries. In the western world, the risk of cardiovascular disease in pregnancy has increased due to the increasing age at the first pregnancy and the worldwide obesity epidemic leading also to early diabetes and hypertension. In addition the treatment of congenital heart disease has improved leading to an increased number of women with residual heart disease reaching childbearing age. In the western world maternal heart disease is now the major cause of maternal death during pregnancy. In the developing world rheumatic heart disease and the cardiomyopathies dominate. Those women often need anticoagulation as they might have had a valve replacement or formed a thrombus in the left heart. Drugs during pregnancy and the breastfeeding period is a complex subject and there is a profound shortage of evidence based recommendations. As drug treatment in pregnancy concern the mother and the fetus optimum treatment of both must be targeted.

This book aims at discussing the most important indications of drug usage in pregnancy and postpartum with the aim of weighing the potential risk of a drug and the possible benefit against each other.​
Edited by:   ,
Imprint:   Springer London Ltd
Country of Publication:   United Kingdom
Edition:   2014 ed.
Dimensions:   Height: 203mm,  Width: 127mm,  Spine: 8mm
Weight:   1.808kg
ISBN:   9781447154716
ISBN 10:   1447154711
Series:   Current Cardiovascular Therapy
Pages:   131
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
​ Introduction.- General principles and guidelines.- Management of Hypertension.- Management of Heart Failure.- Management of  coronary artery disease & Arrhythmia.- Anticoagulation in Pregnancy.- Obstetric drugs in management if Cardiovascular disease.- Pregnancy anaesthesia in patients with cardiovascular disease.​

Professor Karen Sliwa-Hähnle, MD, PhD, FESC, FACC, DTM&H, is Director of the Hatter Institute for Cardiovascular Research in Africa (HICRA) and Professor at the Department of Medicine and Institute of Infectious Diseases and Molecular Medicine University of Cape Town, South Africa. Professor John Anthony, MB, ChB, FCOG, MPhil, is Head of the Department of Obstetrics & Gynaecology at Groote Schuur Hospital, Cape Town, South Africa.    

Reviews for Cardiac Drugs in Pregnancy

This handy book, written by distinguished authors in the field, consists of six chapters illustrating pharmacological treatment of different heart diseases during pregnancy. ... The book is an easy and enjoyable reading. ... the content is easily comprehensible and the book has a universal appeal, as it includes treatment in countries with different facilities. In addition, the pocket format is pleasing and practical for the everyday clinician. (Maria Schaufelberger, European Heart Journal, Vol. 36 (18), 2015)


See Also